|
KMID : 1160420220040010013
|
|
Epilia: Epilepsy Commun
2022 Volume.4 No. 1 p.13 ~ p.19
|
|
|
Epilepsy and COVID-19: Recent Findings and Considerations
|
|
Kim Hyun-Kyung
|
|
|
Abstract
|
|
|
|
As the coronavirus disease 2019 (COVID-19) outbreak enters its third year, it continues to impact social life and medical practice. Although respiratory symptoms are the most important clinical manifestations of COVID-19, COVID-19 can also cause various neurologic manifestations and disorders through neurotropism and collateral injuries. The effects of COVID-19 on seizures and epilepsy have been studied. The COVID-19 pandemic has led to changes in epilepsy care. In addition, concerns regarding the effectiveness and safety of the COVID-19 vaccine in patients with epilepsy are increasing. Epileptologists need to keep up with daily updates in the evidence regarding interactions between COVID-19 and epilepsy.
|
|
|
KEYWORD
|
|
|
COVID-19, Seizure, Epilepsy
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|
|